First Heartland Consultants’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-3,698
Closed -$225K – 367
2022
Q1
$225K Sell
3,698
-3,658
-50% -$218K 0.03% 314
2021
Q4
$484K Sell
7,356
-32
-0.4% -$2.05K 0.02% 203
2021
Q3
$464K Buy
7,388
+14
+0.2% +$893 0.07% 209
2021
Q2
$444K Sell
7,374
-2,154
-23% -$125K 0.07% 230
2021
Q1
$525K Sell
9,528
-576
-6% -$31.9K 0.08% 193
2020
Q4
$551K Buy
10,104
+1,482
+17% +$77.5K 0.09% 157
2020
Q3
$431K Buy
+8,622
New +$418K 0.08% 165
2020
Q1
– Sell
-7,938
Closed -$350K – 273
2019
Q4
$350K Hold
7,938
– – 0.07% 213
2019
Q3
$327K Buy
7,938
+180
+2% +$7.37K 0.07% 218
2019
Q2
$311K Buy
7,758
+684
+10% +$25.9K 0.07% 208
2019
Q1
$273K Buy
+7,074
New +$257K 0.08% 213
2016
Q4
– Sell
-29,346
Closed -$711K – 338
2016
Q3
$711K Buy
29,346
+16,236
+124% +$386K 0.21% 123
2016
Q2
$296K Buy
+13,110
New +$284K 0.03% 230

Other funds holding IHI

First Heartland Consultants's IHI Position: Q2 2022 in Review

First Heartland Consultants sold out of iShares US Medical Devices ETF (IHI) in Q2 2022, closing a stake of 3,698 shares — an estimated $225K sold.

First Heartland Consultants first reported a position in IHI in Q2 2016 and held it in 13 quarters. The position peaked at $711K in Q3 2016. 592 funds tracked by Wall St. Rank hold IHI as of Q2 2022.

  • First Heartland Consultants reported no remaining iShares US Medical Devices ETF position as of Q2 2022 after selling out during the quarter.
  • First Heartland Consultants sold 3,698 iShares US Medical Devices ETF shares in Q2 2022, an estimated $225K.
  • First Heartland Consultants first reported a position in iShares US Medical Devices ETF in Q2 2016 and held it in 13 quarters.
  • First Heartland Consultants's iShares US Medical Devices ETF position peaked at $711K in Q3 2016.
  • 592 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2022.

Based on First Heartland Consultants's 13F filing for Q2 2022, filed 12 Jul 2022.